Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.73 is 98% above its 5-year average of -195.03, near the high end of its 5-year range (-408.48–-3.73).
91.98% above its 12-month average of -46.49.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.64.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.73
EARNINGS PER SHARE (EPS) AVG TTM
-46.49
EARNINGS PER SHARE (EPS) AVG 3Y
-194.14
EARNINGS PER SHARE (EPS) AVG 5Y
-195.03
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+91.98%
CURRENT VS 3Y AVG
+98.08%
CURRENT VS 5Y AVG
+98.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Bionano Genomics, Inc.
Market Cap
$16.70M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$16.73M
Earnings Per Share (EPS)
-4.76
TTM Avg
-17.55
3Y Avg
-9.83
5Y Avg
-7.78
Market Cap
$16.49M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
Market Cap
$17.13M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.99
3Y Avg
-1.87
5Y Avg
-3.18
Market Cap
$17.19M
Earnings Per Share (EPS)
-1.87
TTM Avg
-0.88
3Y Avg
-1.76
5Y Avg
-2.28
Market Cap
$18.31M
Earnings Per Share (EPS)
-16.36
TTM Avg
46.76
3Y Avg
-158.09
5Y Avg
-209.03
Market Cap
$16.00M
Earnings Per Share (EPS)
-0.76
TTM Avg
-2.06
3Y Avg
-5.59
5Y Avg
-9.29
Market Cap
$17.59M
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.90
3Y Avg
-9.28
5Y Avg
-9.88
Market Cap
$15.75M
Earnings Per Share (EPS)
-0.78
TTM Avg
-8.29
3Y Avg
-9461.74
5Y Avg
-302593.36
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.70M | -3.73 | -46.49 | -194.14 | -195.03 |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | -4.76 | -17.55 | -9.83 | -7.78 |
| Dyadic International, Inc. (DYAI)vs › | $16.49M | -0.21 | -0.22 | -0.25 | -0.30 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.13M | -0.48 | -0.99 | -1.87 | -3.18 |
| Lipocine Inc. (LPCN)vs › | $17.19M | -1.87 | -0.88 | -1.76 | -2.28 |
| PAVmed Inc. (PAVM)vs › | $18.31M | -16.36 | 46.76 | -158.09 | -209.03 |
| BioCardia, Inc. (BCDA)vs › | $16.00M | -0.76 | -2.06 | -5.59 | -9.29 |
| Cosmos Health Inc. (COSM)vs › | $17.59M | -0.66 | -0.90 | -9.28 | -9.88 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | -0.78 | -8.29 | -9461.74 | -302593.36 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | -0.77 | -1.25 | -1.82 | -1.86 |
Trailing EPS (TTM)
$-3.73
Forward EPS (Est.)
$-2.14
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.85 |
| 2024-12-31 | -88.13 |
| 2023-12-31 | -408.48 |
| 2022-12-31 | -275.09 |
| 2021-12-31 | -157.02 |
| 2020-12-31 | -236.58 |
| 2019-12-31 | -1194.36 |
| 2018-12-31 | -1568.13 |
| 2017-12-31 | -1402.56 |
| 2016-12-31 | -1131.43 |
